Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies

by Attwa MW, Kadi AA, Abdelhameed AS, Alhazmi HA
Published 2020-02-01